The World’sMost At-Risk Populations.We're in their Corner. ReViral brings together the experience & passion needed to transform the treatment of viral infections — starting with RSV. We’re committed to developing antiviral therapies to help the world’s most at-risk populations. Learn More Recent News Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic CandidatesApr 7, 2022 ReViral Appoints Brett Haumann as Chief Medical OfficerJan 17, 2022 More News